VEGFA and ovarian neoplasm: To further confirm the role of decreased VEGF activity induced by treatment with celecoxib in the formation of blood vessels, we analyzed the treated ovarian tumors through staining with the endothelial cell marker, CD31 (Figure 5C and 5D).